Healthcare provider profile · identity verified

Mali Him

Family Practice · ROCKFORD, IL · NPI 1295031102

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	536	169
Amlodipine Besylate	Amlodipine Besylate	515	154
Levothyroxine Sodium	Levothyroxine Sodium	424	115
Lisinopril	Lisinopril	422	128
Hydrochlorothiazide	Hydrochlorothiazide	271	82
Omeprazole	Omeprazole	268	75
Metformin Hcl	Metformin Hcl	229	71
Metoprolol Succinate	Metoprolol Succinate	181	58
Losartan Potassium	Losartan Potassium	179	59
Rosuvastatin Calcium	Rosuvastatin Calcium	166	50
Simvastatin	Simvastatin	150	44
Albuterol Sulfate Hfa	Albuterol Sulfate	144	46
Gabapentin	Gabapentin	143	35
Tramadol Hcl	Tramadol Hcl	135	46
Metoprolol Tartrate	Metoprolol Tartrate	127	35
Pantoprazole Sodium	Pantoprazole Sodium	122	30
Pravastatin Sodium	Pravastatin Sodium	116	34
Furosemide	Furosemide	110	39
Alprazolam	Alprazolam	97	27
Trazodone Hcl	Trazodone Hcl	90	22
Carvedilol	Carvedilol	89	29
Azithromycin	Azithromycin	88	73
Eliquis	Apixaban	86	21
Ozempic	Semaglutide	85	13
Jardiance	Empagliflozin	84	23
Alendronate Sodium	Alendronate Sodium	83	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	83	23
Escitalopram Oxalate	Escitalopram Oxalate	79	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	22
Metformin Hcl Er	Metformin Hcl	74	22
Duloxetine Hcl	Duloxetine Hcl	72	20
Sertraline Hcl	Sertraline Hcl	72	22
Glipizide	Glipizide	67	25
Spironolactone	Spironolactone	67	18
Allopurinol	Allopurinol	62	18
Cephalexin	Cephalexin	59	48
Januvia	Sitagliptin Phosphate	59	16
Clopidogrel	Clopidogrel Bisulfate	58	15
Hydralazine Hcl	Hydralazine Hcl	57	18
Montelukast Sodium	Montelukast Sodium	55	15
Glipizide Er	Glipizide	54	16
Tamsulosin Hcl	Tamsulosin Hcl	53	20
Atenolol	Atenolol	51	15
Meloxicam	Meloxicam	51	20
Tizanidine Hcl	Tizanidine Hcl	50	suppressed
Warfarin Sodium	Warfarin Sodium	50	15
Mounjaro	Tirzepatide	49	11
Fluticasone Propionate	Fluticasone Propionate	47	15
Potassium Chloride	Potassium Chloride	47	25
Ezetimibe	Ezetimibe	46	13
Fluoxetine Hcl	Fluoxetine Hcl	46	15
Hydroxyzine Hcl	Hydroxyzine Hcl	45	18
Meclizine Hcl	Meclizine Hcl	42	19
Xarelto	Rivaroxaban	40	suppressed
Baclofen	Baclofen	39	suppressed
Clonazepam	Clonazepam	38	suppressed
Famotidine	Famotidine	38	15
Pregabalin	Pregabalin	38	suppressed
Irbesartan	Irbesartan	37	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	13
Naproxen	Naproxen	36	14
Amitriptyline Hcl	Amitriptyline Hcl	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	34	11
Doxycycline Hyclate	Doxycycline Hyclate	33	29
Oxybutynin Chloride	Oxybutynin Chloride	33	12
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Methylprednisolone	Methylprednisolone	31	30
Prednisone	Prednisone	30	25
Benazepril Hcl	Benazepril Hcl	28	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	28	suppressed
Lovastatin	Lovastatin	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Fenofibrate	Fenofibrate,micronized	25	suppressed
Nitroglycerin	Nitroglycerin	25	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Gemfibrozil	Gemfibrozil	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	12
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Solifenacin Succinate	Solifenacin Succinate	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	20	suppressed
Betamethasone Valerate	Betamethasone Valerate	19	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Trulicity	Dulaglutide	18	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Linzess	Linaclotide	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	12
Entresto	Sacubitril/Valsartan	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Finasteride	Finasteride	12	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error